CN

  • 2023

    Sep.

    Singed Exclusive Rights To Commercialize BTM101 in Mainland China，Hong Kong and Macao

    May

    IND application for BTM002 approved by NMPA

  • 2021

    Jan.

    Completed Round pre-A financing

  • 2020

    Aug.

    Signed the exclusive rights to commercialize BTM001, BTM002 and BTM003 in Mainland China region

  • 2019

    Dec.

    Signed the exclusive rights to promote Pellefeel and PTLenus in Great China region

    Oct.

    Launched BTM’s China operation center in Shanghai

    Sep.

    Established Jiangsu Better Time Biotechnology Co., Ltd.